Genetic landscape of sporadic vestibular schwannoma

被引:52
|
作者
Havik, Aril Loge [1 ,2 ,5 ]
Bruland, Ove [5 ]
Myrseth, Erling [6 ]
Miletic, Hrvoje [3 ,4 ,7 ]
Aarhus, Mads [8 ]
Knappskog, Per-Morten [2 ,5 ]
Lund-Johansen, Morten [1 ,4 ,6 ]
机构
[1] Univ Bergen, Dept Clin Med, Bergen, Norway
[2] Univ Bergen, Dept Clin Sci, Bergen, Norway
[3] Univ Bergen, Dept Biomed, Bergen, Norway
[4] Univ Bergen, KG Jebsen Brain Tumor Res Ctr, Bergen, Norway
[5] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway
[6] Haukeland Hosp, Dept Neurosurg, N-5009 Bergen, Norway
[7] Haukeland Hosp, Dept Pathol, Bergen, Norway
[8] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway
关键词
vestibular schwannoma; NF2; axonal guidance; next-generation sequencing; molecular biology; USP8; CDC27; COMPARATIVE GENOMIC HYBRIDIZATION; NEUROFIBROMATOSIS TYPE-2 GENE; MALIGNANT-TRANSFORMATION; MICROARRAY ANALYSIS; MERLIN; CANCER; PHOSPHORYLATION; SUPPRESSOR; EXPRESSION; MUTATIONS;
D O I
10.3171/2016.10.JNS161384
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Vestibular schwannoma (VS) is a benign tumor with associated morbidities and reduced quality of life. Except for mutations in NF2, the genetic landscape of VS remains to be elucidated. Little is known about the effect of Gamma Knife radiosurgery (GKRS) on the VS genome. The aim of this study was to characterize mutations occurring in this tumor to identify new genes and signaling pathways important for the development of VS. In addition, the authors sought to evaluate whether GKRS resulted in an increase in the number of mutations. METHODS Forty-six sporadic VSs, including 8 GKRS-treated tumors and corresponding blood samples, were subjected to whole-exome sequencing and tumor-specific DNA variants were called. Pathway analysis was performed using the Ingenuity Pathway Analysis software. In addition, multiplex ligation-dependent probe amplification was performed to characterize copy number variations in the NF2 gene, and microsatellite instability testing was done to investigate for DNA replication error. RESULTS With the exception of a single sample with an aggressive phenotype that harbored a large number of mutations, most samples showed a relatively low number of mutations. A median of 14 tumor-specific mutations in each sample were identified. The GKRS-treated tumors harbored no more mutations than the rest of the group. A clustering of mutations in the cancer-related axonal guidance pathway was identified (25 patients), as well as mutations in the CDC27 (5 patients) and USP8 (3 patients) genes. Thirty-five tumors harbored mutations in NF2 and 16 tumors had 2 mutational hits. The samples without detectable NF2 mutations harbored mutations in genes that could be linked to NF2 or to NF2-related functions. None of the tumors showed microsatellite instability. CONCLUSIONS The genetic landscape of VS seems to be quite heterogeneous; however, most samples had mutations in NF2 or in genes that could be linked to NF2. The results of this study do not link GKRS to an increased number of mutations.
引用
收藏
页码:911 / 922
页数:12
相关论文
共 50 条
  • [31] Efficacy of aspirin for sporadic vestibular schwannoma: a meta-analysis
    Katrina Hannah D. Ignacio
    Adrian I. Espiritu
    Jose Danilo B. Diestro
    Kevin Ivan Chan
    Adam A. Dmytriw
    Abdelsimar T. Omar
    Neurological Sciences, 2021, 42 : 5101 - 5106
  • [32] Therapy of Sporadic and NF2-Related Vestibular Schwannoma
    Yao, Longping
    Alahmari, Mohammed
    Temel, Yasin
    Hovinga, Koos
    CANCERS, 2020, 12 (04)
  • [33] Hearing Preservation in Observed Sporadic Vestibular Schwannoma: A Systematic Review
    Khandalavala, Karl R.
    Saba, Elias S.
    Kocharyan, Armine
    Daher, Ghazal S.
    Lohse, Christine M.
    Marinelli, John P.
    Carlson, Matthew L.
    OTOLOGY & NEUROTOLOGY, 2022, 43 (06) : 604 - 610
  • [34] Efficacy of aspirin for sporadic vestibular schwannoma: a meta-analysis
    Ignacio, Katrina Hannah D.
    Espiritu, Adrian I.
    Diestro, Jose Danilo B.
    Chan, Kevin Ivan
    Dmytriw, Adam A.
    Omar, Abdelsimar T., II
    NEUROLOGICAL SCIENCES, 2021, 42 (12) : 5101 - 5106
  • [35] What Drives Quality of Life in Patients With Sporadic Vestibular Schwannoma?
    Carlson, Matthew L.
    Tveiten, Oystein Vesterli
    Driscoll, Colin L.
    Goplen, Frederik K.
    Neff, Brian A.
    Pollock, Bruce E.
    Tombers, Nicole M.
    Lund-Johansen, Morten
    Link, Michael J.
    LARYNGOSCOPE, 2015, 125 (07) : 1697 - 1702
  • [36] Surgical treatment of sporadic vestibular schwannoma in a series of 1006 patients
    Zhang, Z.
    Nguyen, Y.
    De Seta, D.
    Russo, F. Y.
    Rey, A.
    Kalamarides, M.
    Sterkers, O.
    Bernardeschi, D.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2016, 36 (05) : 408 - 414
  • [37] Long-Term Outcomes of Stereotactic Radiosurgery for Vestibular Schwannoma Associated with Neurofibromatosis Type 2 in Comparison to Sporadic Schwannoma
    Shinya, Yuki
    Hasegawa, Hirotaka
    Shin, Masahiro
    Sugiyama, Takehiro
    Kawashima, Mariko
    Takahashi, Wataru
    Iwasaki, Shinichi
    Kashio, Akinori
    Nakatomi, Hirofumi
    Saito, Nobuhito
    CANCERS, 2019, 11 (10)
  • [38] The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma
    Gregory, Grace E.
    Jones, Adam Paul
    Haley, Michael J.
    Hoyle, Christopher
    Zeef, Leo A. H.
    Lin, I-Hsuan
    Coope, David J.
    King, Andrew T.
    Evans, D. Gareth
    Paszek, Pawel
    Couper, Kevin N.
    Brough, David
    Pathmanaban, Omar N.
    BRAIN COMMUNICATIONS, 2023, 5 (04)
  • [39] Updates on Tumor Biology in Vestibular Schwannoma
    Nourbakhsh, Aida
    Dinh, Christine T.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2023, 56 (03) : 421 - 434
  • [40] Natural History of Sporadic Vestibular Schwannoma: A Volumetric Study of Tumor Growth
    Lees, Katherine A.
    Tombers, Nicole M.
    Link, Michael J.
    Driscoll, Colin L.
    Neff, Brian A.
    Van Gompel, Jamie J.
    Lane, John I.
    Lohse, Christine M.
    Carlson, Matthew L.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2018, 159 (03) : 535 - 542